Suppr超能文献

脑积水患者行脑室腹腔分流术或脑室心房分流术后迟发性导管相关颅内出血

Delayed Catheter-Related Intracranial Hemorrhage After a Ventriculoperitoneal or Ventriculoatrial Shunt in Hydrocephalus.

作者信息

Qian Zhouqi, Gao Liang, Wang Ke, Pandey Sajan

机构信息

Neurosurgical Department, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.

Neurosurgical Department, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.

出版信息

World Neurosurg. 2017 Nov;107:846-851. doi: 10.1016/j.wneu.2017.08.098. Epub 2017 Aug 25.

Abstract

OBJECTIVE

Delayed catheter-related intracranial hemorrhage is not rare after a ventriculoperitoneal (VP) or ventriculoatrial (VA) shunt for the treatment of hydrocephalus. Immediate postoperative catheter-related intracranial hemorrhage is possibly due to the procedure itself; however, delayed intracranial hemorrhage may have other underlying mechanisms. This study aimed to investigate the clinical characteristics and reveal the risk factors of delayed catheter-related intracranial hemorrhage after a VP or VA shunt.

METHODS

We did a retrospective study to review patients with hydrocephalus and underwent VP or VA shunt in our department from September 2011 to December 2015. We reviewed the clinical characteristics of the patients with delayed catheter-related intracranial hemorrhage, and its risk factors were analyzed with SPSS 16.0.

RESULTS

Of the 218 patients enrolled in the study (145 male, 73 female), 17 (7.8%) patients experienced delayed catheter-related intracranial hemorrhage, including 11 of 151 (7.3%) patients with a VP shunt and 6 of 67 (9.0%) patients with a VA shunt. Additionally, 4 of the 16 patients with postoperative low-molecular-weight heparin (LMWH) therapy and 13 of the 202 patients without LMWH experienced bleeding, showing a significant difference (25% vs. 6.4%, P = 0.026). The relative risk was 4.8 (95% confidence interval: 1.4-17.1).

CONCLUSION

Delayed catheter-related intracranial hemorrhage is not rare after a VP or VA shunt. However, most patients can be cured after appropriate treatment. Postoperative anticoagulation therapy with enoxaparin may be associated with an increased risk of bleeding.

摘要

目的

在用于治疗脑积水的脑室腹腔(VP)或脑室心房(VA)分流术后,迟发性导管相关颅内出血并不罕见。术后即刻发生的导管相关颅内出血可能归因于手术本身;然而,迟发性颅内出血可能有其他潜在机制。本研究旨在调查VP或VA分流术后迟发性导管相关颅内出血的临床特征并揭示其危险因素。

方法

我们进行了一项回顾性研究,以回顾2011年9月至2015年12月在我科接受VP或VA分流术的脑积水患者。我们回顾了迟发性导管相关颅内出血患者的临床特征,并使用SPSS 16.0分析其危险因素。

结果

在纳入研究的218例患者中(男性145例,女性73例),17例(7.8%)患者发生了迟发性导管相关颅内出血,其中151例接受VP分流术的患者中有11例(7.3%),67例接受VA分流术的患者中有6例(9.0%)。此外,16例接受术后低分子量肝素(LMWH)治疗的患者中有4例出血,202例未接受LMWH治疗的患者中有13例出血,差异有统计学意义(25%对6.4%,P = 0.026)。相对风险为4.8(95%置信区间:1.4 - 17.1)。

结论

VP或VA分流术后迟发性导管相关颅内出血并不罕见。然而,大多数患者经适当治疗后可治愈。术后使用依诺肝素进行抗凝治疗可能会增加出血风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验